A new drug has been found to slow the progression of Alzheimer's, with experts hailing it as a "turning point".

Donanemab was shown to reduce cognitive decline by up to 35 percent, if the disease is detected early.

Roger Highfield, Science Director at the London Science Museum joined Kieran to discuss...